AZ's rare disease Ultomiris snags 3rd FDA nod
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
Alexion
Alexion Pharmaceuticals
Alexion asked AstraZeneca to up its buyout offer multiple times—almost costing it a deal in the process | Fierce Pharma
AstraZeneca's Alexion to amplify the voices of rare disease, with a focus on diversity in diagnosis | Fierce Pharma
Word Template
Alexion to Build New Offices - WSJ
Alexion Irish Factory Gets A $68.7M Upgrade From AstraZeneca | World Pharma Today
Medica RCP | Companies |Alexion Pharma
AstraZeneca Alexion's Ultomiris approved in Europe for gMG - DirectorsTalk Interviews
Alexion will invest €450 million to expand to Dublin - Labiotech.eu
Alexion
Alexion
Articles about Alexion
AstraZeneca gets EU clearance on Alexion - P.M. News
Alexion - HB Design
UK regulator reviewing AstraZeneca's $39 bln Alexion buyout | Reuters
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal - MarketWatch
Alexion clears acquisition hurdles; Thetis gets $1.9M grant; Precipio signs European distribution deal | New Haven BIZ
AstraZeneca Receives European Commission Approval to Acquire Alexion for $39 billion | Healthcare Business Club
Alexion to expand biologics manufacturing with €65m investment
Alexion Says Senior Management Improperly Pressured Staff to Boost Sales - WSJ
European marketing authorisation for Kanuma™
AstraZeneca's Alexion Splurge Could Attract a Crowd - WSJ
